MPWM Advisory Solutions’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$184K Sell
6,538
-12
-0.2% -$319 0.1% 107
2025
Q4
$163K Buy
6,550
+1,821
+39% +$45.9K 0.09% 101
2025
Q3
$121K Sell
4,729
-1,570
-25% -$38.8K 0.07% 106
2025
Q2
$153K Sell
6,299
-347
-5% -$8.09K 0.1% 93
2025
Q1
$168K Buy
6,646
+825
+14% +$21.6K 0.12% 74
2024
Q4
$154K Buy
+5,821
New +$158K 0.11% 82

Other funds holding PFE

MPWM Advisory Solutions's PFE Position: Q1 2026 in Review

MPWM Advisory Solutions reduced its Pfizer (PFE) stake by 0.18% in Q1 2026, selling an estimated $319 and leaving 6,538 shares worth $184K. The position accounts for 0.1% of the portfolio, ranked #107.

MPWM Advisory Solutions first reported a position in PFE in Q4 2024 and has held it in 6 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • MPWM Advisory Solutions held 6,538 shares of Pfizer worth $184K as of Q1 2026.
  • MPWM Advisory Solutions sold 12 Pfizer shares in Q1 2026, an estimated $319.
  • Pfizer made up 0.1% of MPWM Advisory Solutions's portfolio in Q1 2026, its #107 holding.
  • MPWM Advisory Solutions first reported a position in Pfizer in Q4 2024 and has held it in 6 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on MPWM Advisory Solutions's 13F filing for Q1 2026, filed 13 May 2026.